+

WO2008023268A3 - Modèle d'un cancer prolongé exprimant de façon conditionnelle un oncogène chez la souris - Google Patents

Modèle d'un cancer prolongé exprimant de façon conditionnelle un oncogène chez la souris Download PDF

Info

Publication number
WO2008023268A3
WO2008023268A3 PCT/IB2007/003288 IB2007003288W WO2008023268A3 WO 2008023268 A3 WO2008023268 A3 WO 2008023268A3 IB 2007003288 W IB2007003288 W IB 2007003288W WO 2008023268 A3 WO2008023268 A3 WO 2008023268A3
Authority
WO
WIPO (PCT)
Prior art keywords
bcr
mouse model
abl oncogene
relates
conditionally expressing
Prior art date
Application number
PCT/IB2007/003288
Other languages
English (en)
Other versions
WO2008023268A2 (fr
Inventor
Isidro Sanchez-Garcia
Maria Perez-Caro
Original Assignee
Univ Salamanca
Consejo Superior Investigacion
Isidro Sanchez-Garcia
Maria Perez-Caro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Salamanca, Consejo Superior Investigacion, Isidro Sanchez-Garcia, Maria Perez-Caro filed Critical Univ Salamanca
Publication of WO2008023268A2 publication Critical patent/WO2008023268A2/fr
Publication of WO2008023268A3 publication Critical patent/WO2008023268A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biophysics (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne le développement du cancer, de façon plus précise, de la leucémie. En particulier, l'invention concerne des animaux transgéniques comprenant, dans leur génome, un oncogène humain qui peut être régulé de façon exogène par une substance effectrice. L'invention concerne en outre des animaux transgéniques comprenant, dans leur génome, le gène BCR-ABLp 190. De plus, l'invention concerne l'utilisation des mammifères non humains transgéniques de l'invention pour la découverte et le développement de composés pour la prévention et/ou le traitement du cancer.
PCT/IB2007/003288 2006-08-24 2007-08-23 Modèle d'un cancer prolongé exprimant de façon conditionnelle un oncogène chez la souris WO2008023268A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06017630 2006-08-24
EP06017630.2 2006-08-24

Publications (2)

Publication Number Publication Date
WO2008023268A2 WO2008023268A2 (fr) 2008-02-28
WO2008023268A3 true WO2008023268A3 (fr) 2008-07-31

Family

ID=39107179

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/003288 WO2008023268A2 (fr) 2006-08-24 2007-08-23 Modèle d'un cancer prolongé exprimant de façon conditionnelle un oncogène chez la souris

Country Status (1)

Country Link
WO (1) WO2008023268A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007489A1 (fr) * 1989-11-22 1991-05-30 Childrens Hospital Of Los Angeles Animaux transgeniques bcr/abl utilises comme modeles de la leucemie myelogene chronique positive et lymphoplastique aigue du chromosome de philadelphie

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007489A1 (fr) * 1989-11-22 1991-05-30 Childrens Hospital Of Los Angeles Animaux transgeniques bcr/abl utilises comme modeles de la leucemie myelogene chronique positive et lymphoplastique aigue du chromosome de philadelphie
US5849996A (en) * 1989-11-22 1998-12-15 Childrens Hospital Of Los Angeles BCR/ABL transgenic animals as models for Philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BRAIN JULIA M ET AL: "The kinase inhibitor STI571 reverses the Bcr-Abl induced point mutation frequencies observed in pre-leukemic P190Bcr-Abl transgenic mice.", LEUKEMIA RESEARCH, vol. 26, no. 11, November 2002 (2002-11-01), pages 1011 - 1016, XP002480384, ISSN: 0145-2126 *
CHOO Y ET AL: "IN VIVO REPRESSION BY A SITE-SPECIFIC DNA-BINDING PROTEIN DESIGNED AGAINST AN ONCOGENIC SEQUENCE", NATURE, NATURE PUBLISHING GROUP, LONDON, vol. 372, 15 December 1994 (1994-12-15), pages 642 - 645, XP000986225, ISSN: 0028-0836 *
COBALEDA C ET AL: "In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: A novel approach for cancer treatment", BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, vol. 95, no. 3, 1 February 2000 (2000-02-01), pages 731 - 737, XP002239466, ISSN: 0006-4971 *
GARCÍA-HERNÁNDEZ B ET AL: "Retroviral vector design for gene therapy of cancer: specific inhibition and tagging of BCR-ABLp190 cells.", MOLECULAR MEDICINE (CAMBRIDGE, MASS.) JAN 1996, vol. 2, no. 1, January 1996 (1996-01-01), pages 125 - 133, XP001013586, ISSN: 1076-1551 *
PEREZ-CARO M ET AL: "Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice", ONCOGENE, vol. 26, no. 12, March 2007 (2007-03-01), pages 1702 - 1713, XP002480386, ISSN: 0950-9232 *
VITALE-CROSS LYNN ET AL: "Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis", CANCER RESEARCH, vol. 64, no. 24, 15 December 2004 (2004-12-15), pages 8804 - 8807, XP002480385, ISSN: 0008-5472 *

Also Published As

Publication number Publication date
WO2008023268A2 (fr) 2008-02-28

Similar Documents

Publication Publication Date Title
IL195411A0 (en) Real time, on the fly, distribution of pre-selected electronic content
AP2414A (en) Fungicidal aqueous compositions for seed treatment.
HK1096555A1 (en) Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase -13
WO2007141274A3 (fr) Molécules de liaison humaines présentant une activité bactéricide contre les staphylocoques et leurs utilisations
WO2009077443A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
AP2012006217A0 (en) Soybean transgenic event mon 87708 and methods of use thereof.
WO2007117511A3 (fr) Préparations alimentaires contenant de l'acide docosahexaénoïque
PL2546253T3 (pl) Podstawione dihydropirazolony do leczenia schorzeń sercowo-naczyniowych i hematologicznych
AP2012006325A0 (en) Transgenic maize event mon 87427 and the relative development scale.
WO2009077500A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
PL387008A1 (pl) Sposób oczyszczania triorganofosforynów przez obróbkę dodatkiem zasadowym
WO2009077471A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
PH12008500597A1 (en) Use of lactate esters for improving the action of agricultural pesticides
GB0605715D0 (en) Treatment of laminitis
GB2434732B (en) Manufacture of animal feed supplements
WO2008011990A3 (fr) Mélanges insecticides synergiques
WO2007002881A3 (fr) Compositions et procedes pour utiliser des flavanols derives
WO2008023268A3 (fr) Modèle d'un cancer prolongé exprimant de façon conditionnelle un oncogène chez la souris
FR2946881B1 (fr) Activite multimodale d'oligonucleotides g-quartet et compositions microbicides.
GB0606868D0 (en) Animal deterrent
GB0507490D0 (en) Treatment of animal parasites
WO2009038089A1 (fr) Agent anti-fatigue contenant de la sésamine et de la vitamine e
SI2010514T1 (sl) 3-(piridin-2-il)-(1,2,4)-triazini uporabni kot fungicidi
Aoyagi You are what you eat!

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07825546

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07825546

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载